Navigation Links
NeoStem Forges Ahead in Its Plan to Open Adult Stem Cell Collection Centers in Key Locations that Can Serve as Hubs to Service Clients Nationwide
Date:8/5/2008

NEW YORK, Aug. 5 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS) announced today that the new Southern Florida stem cell collection center located in Coral Gables, a suburb of Miami, is targeted to open in September. The center is being opened pursuant to an agreement with CelVida LLC. With the opening of this center, NeoStem has secured a key geographic stronghold in an area that is open to a large U.S. market as well as a growing sophisticated South American presence.

Chester Amedia, Jr. MD, FACP, is the Founder and President of CelVida LLC and has had extensive business and patient care experience in the fields of disease management and extracorporeal therapy. "We are thrilled to be part of what many believe to be an emerging "Stem Cell Revolution" and have chosen to strategically align with NeoStem to provide individuals looking for a proactive approach to their future medical care the opportunity to have their stem cells collected and preserved for use in the future in the event of medical need," stated Dr. Amedia. "It is estimated that by 2017 there will be as many as 2 million annual procedures that will include stem cell based therapies for diabetes, orthopedic injuries, cardiovascular disease, inflammatory diseases, among others."

"We are thrilled to be working with such an accomplished physician who has demonstrated success in building a flourishing medical business. We believe that patient specific stem cell collection and storage one day will be viewed as being as routine as securing health insurance. We continue to see an abundance of evidence in the scientific literature as data from clinical trials supports the proposition that autologous adult stem cell therapies are emerging as an important measure in repairing degenerated, damaged and diseased tissue (the three "Ds" of aging)," said Robin Smith, MD, CEO of NeoStem.

About CelVida LLC

CelVida was organized to develop a network of personal self-care centers in key metropolitan markets around the country. The CelVida network intends to make the simple process of stem cell collection and storage available to individuals proactively seeking healthcare options that embrace new technologies.

About NeoStem, Inc.

NeoStem is managing a network of adult stem cell collection centers, enabling people (through its proprietary technology) to donate and store their own (autologous) stem cells when they are young and/or relatively healthy for their personal use in times of future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's periodic filings with the Securities and Exchange Commission.

Contact:

NeoStem, Inc.

Robin Smith, Chief Executive Officer

T: 212-584-4180

E: rsmith@neostem.com

http://www.neostem.com


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NeoStem Expands Adult Stem Cell Collection Network, Gains Footprint in Key Los Angeles Market and Initiates Waitlist
2. Suzanne Somers To Promote Growing Importance of Storing Your Own Adult Stem Cells Under Alliance With NeoStem, Inc.
3. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
4. NeoStem to Expand Stem Cell Collection Center Network to Florida
5. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
6. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
7. NeoStem to Present at Third Annual Stem Cell Summit in New York City
8. NeoStem Announces NY State License for Adult Stem Cell Collection
9. Principle of Recursive Genome Function Supersedes Dogmas; By Andras Pellionisz, Online Ahead of Print; (Scientific Visionary Vindicated)
10. Breakthroughs Ahead, Endocrine Society Tells Security Analysts
11. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in ... Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio ... practical tips, tools, and strategies for clinical researchers. , “The landscape of how ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... , June 23, 2016 A person commits ... the crime scene to track the criminal down. ... U.S. Food and Drug Administration (FDA) uses DNA evidence to ... Sound far-fetched? It,s not. The FDA has ... to support investigations of foodborne illnesses. Put as simply as ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):